Evidence map›Paper›PMID 38357246›Full record

ArticleACS ES&T engineering2024

High Efficacy Two-Stage Metal Treatment Incorporating Basic Oxygen Furnace Slag and Microbiological Sulfate Reduction.

Evelyn M Miranda, Caleb M McLaughlin, Jeffrey K Reep, Michael Edgar, Colton Landrum, Carli Severson, Dennis G Grubb, Nasser Hamdan, Shane Hansen, Leonard Santisteban and 1 more

Abstract read
In one paragraph

Article in ACS ES&T engineering, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Evelyn M MirandaBiodesign Swette Center for Environmental Biotechnology, Arizona State University, 1001 S. McAllister Avenue, Tempe, Arizona 85287, United States.
Caleb M McLaughlinBiodesign Swette Center for Environmental Biotechnology, Arizona State University, 1001 S. McAllister Avenue, Tempe, Arizona 85287, United States.
Jeffrey K ReepBiodesign Swette Center for Environmental Biotechnology, Arizona State University, 1001 S. McAllister Avenue, Tempe, Arizona 85287, United States.
Michael EdgarBiodesign Swette Center for Environmental Biotechnology, Arizona State University, 1001 S. McAllister Avenue, Tempe, Arizona 85287, United States.
Colton LandrumBiodesign Swette Center for Environmental Biotechnology, Arizona State University, 1001 S. McAllister Avenue, Tempe, Arizona 85287, United States.
Carli SeversonBiodesign Swette Center for Environmental Biotechnology, Arizona State University, 1001 S. McAllister Avenue, Tempe, Arizona 85287, United States.
Dennis G GrubbJacobs Engineering, 2001 Market St., Suite 900, Philadelphia, Pennsylvania 19104, United States.
Nasser HamdanEngineering Research Center for Bio-Mediated & Bio-Inspired Geotechnics (CBBG), Arizona State University, 425 E. University Dr., Tempe, Arizona 85281, United States.
Shane HansenFreeport-McMoRan Inc., 800 E. Pima Mine Road, Sahuarita, Arizona 85629, United States.
Leonard SantistebanFreeport-McMoRan Inc., 800 E. Pima Mine Road, Sahuarita, Arizona 85629, United States.
Anca G DelgadoBiodesign Swette Center for Environmental Biotechnology, Arizona State University, 1001 S. McAllister Avenue, Tempe, Arizona 85287, United States.ORCID https://orcid.org/0000-0002-9354-0246

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lignocellulosic sulfate-reducing biochemical reactors (SRBRs) can be implemented as passive treatment for mining-influenced water (MIW) mitigating the potentially deleterious effects of MIW acidic pH, and high concentrations of metal(loid)s and SO

Identifiers

PMID38357246
PMCPMC10862489

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.